0000000000991849

AUTHOR

Michael Engelbrecht Nielsen

showing 2 related works from this author

The kinetics of antibody production in mucus and serum of European eel (Anguilla anguilla L.) after vaccination against Vibrio vulnificus: developmen…

2003

Abstract Vibrio vulnificus serovar E, a bacterial pathogen for eels cultured in intensive systems, is transmitted through water and enters into new hosts mainly via gills. The main objective of this work was to study the kinetics of antibody production to V. vulnificus in serum and mucus and their relationship with protection after vaccination. To quantify local mucus antibodies, a new ‘in situ’ dot blot immunoassay using image analysis has been developed. This assay was applied to measure antibody production in the skin zone next to the gills. We found that (i) the immune response in mucus was faster (peak at days 3–4) and shorter in duration (titres significantly elevated up to day 5 and …

SerotypeGillanimal structuresImmunoblottingDot blotEnzyme-Linked Immunosorbent AssayVibrio vulnificusAquatic ScienceMicrobiologyFish DiseasesImmune systemImage Processing Computer-AssistedAnimalsEnvironmental ChemistryVibrio vulnificusPathogenSkinbiologyVaccinationGeneral MedicineAnguillabiology.organism_classificationAntibodies BacterialMucusKineticsMucusVibrio InfectionsBacterial Vaccinesbiology.proteinAntibodyFish & Shellfish Immunology
researchProduct

Field testing of a vaccine against eel diseases caused by Vibrio vulnificus

2001

The field results of a vaccination programme against Vibrio vulnificus serovar E (biotype 2) in a Spanish eel farm are reported. A total of 9.5 million glass eels were vaccinated from January 1998 to March 2000 by prolonged immersion followed by 2 subsequent reimmunisations after 12 to 14 and 24 to 28 d, respectively. The acquired protection and the immune response against serovar E were estimated over a period of 6 mo after vaccination. A similar vaccination schedule was conducted with elvers in a Danish eel farm. In this case, the acquired protection and the immune response against serovar E and the new eel-pathogenic serovars, recently described in Denmark, were evaluated over a short te…

Serotypeendocrine systemTime Factorsanimal structuresVaccination scheduleField vaccination. vibriosisVibrio vulnificus biotype 2Eel vaccinesVibrio vulnificusAquatic Science:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyFish DiseasesImmune systemVibrionaceaeAnguillidaeUNESCO::CIENCIAS DE LA VIDAAnimalsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología)Vibrio vaccinesEcology Evolution Behavior and SystematicsVaccination by prolonged immersionVibrioEels:CIENCIAS DE LA VIDA::Biología animal (Zoología) [UNESCO]biologyVibrio vulnificus serovar E ; Vibrio vulnificus biotype 2 ; Eel vaccines ; Vibrio vaccines ; Vaccination by prolonged immersion ; Field vaccination. vibriosisBody WeightVaccinationbiology.organism_classificationAntibodies BacterialVaccinationVibrio vulnificus serovar EVibrio InfectionsHumoral immunityBacterial Vaccines
researchProduct